Search - tctmd.com

Displaying 361 - 380 of 427

Sort: Relevancy | Date

Presentation TCT 2013

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Presenter: Yuki Horita, Masatoshi Ikeda, Isao Inoki, Masanobu Namura, Kenji Sakata, Hedenobu Terai

January 31, 2013

Presentation TCT 2013

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Presenter: Maxwell Afari, Armando Tellez, Yanping Cheng, Seung-Jin Oh, Piotr Buszman, Krzysztof Milewski, Jong Shiuan Yeh, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients

Presenter: Samer Somi, Wouter Remkes, Jan-Henk Dambrink, Marcel Gosselink, Jan Hoorntje, Harry Suryapranata, Jan Paul Ottervanger, Arnoud van 't Hof

January 31, 2013

Presentation TCT 2013

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp

January 31, 2013

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

Presentation TCT 2012

Case 3: Management of Late Restenosis Due to Neoatherosclerosis with Plaque Rupture

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

Update: Everything You Need to Know about Treatment of Restenosis in 2012

Presenter: Alan Yeung

October 26, 2012

Presentation TCT 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

Presenter: Robert Byrne

October 26, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Presenter: Evelyn Regar

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

Presenter: James Goldstein

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

IVUS Assessment of Stent Thrombosis and Restenosis

Presenter: Soo-Jin Kang

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

News Conference News TCT 2012

Advertisement

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Does direct DES stenting reduces restenosis; a randomized comparison of direct stent implantation to stenting with predilation or provisional stenting in elective PCI patients

Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Case 3: Management of Late Restenosis Due to Neoatherosclerosis with Plaque Rupture

Update: Everything You Need to Know about Treatment of Restenosis in 2012

ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from OCT

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from Grayscale and VH-IVUS

Mechanisms and Predictors of Stent Thrombosis and Restenosis: Insights from NIRS

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

IVUS Assessment of Stent Thrombosis and Restenosis

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Positive Results Seen with Angioplasty for Critical Hand Ischemia

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

Evaluation and Treatment of In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content